Back to Erste Asset Management GmbH Erste Asset Management GmbH

HALOHALO
Showing 8 of 30 quarters

Position history for Erste Asset Management GmbHErste Asset Management GmbH's holdings in HALOZYME THERAPEUTICS INC

Erste Asset Management GmbH holds 34,800 shares of HALO (HALOZYME THERAPEUTICS INC), worth $2.7M as of 2026-Q2. The position was decreased (-68.7% shares). HALO represents 0.0% of Erste Asset Management GmbH's portfolio.

Current Value

$2.7M

Current Shares

34,800

Total Value Change

-$37,302

Total Shares Change

-13,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
34,800
-68.7%
$2.7M0.0%$78.27
0
2026-Q1
Increased
111,300
+219.8%
$6.9M0.1%$69.40
44
2025-Q4
Unchanged
34,800
0.0%
$2.4M0.0%$67.70
0
2025-Q3
Unchanged
34,800
0.0%
$2.6M0.0%$73.29
0
2025-Q2
Decreased
34,800
-27.2%
$1.8M0.0%$52.21
0
2025-Q1
Unchanged
47,800
0.0%
$3.1M0.0%$63.84
0
2024-Q4
Unchanged
47,800
0.0%
$2.3M0.0%$47.99
0
2024-Q3
Unchanged
47,800
0.0%
$2.7M0.0%$56.97
0

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used